Acknowledgement
This research was supported by the Basic Science Research Program (NRF-2019R1A2C3006155) of the National Research Foundation funded by the Korean government.
References
- Kim J, Chang DY, Lee HW et al (2018) Innate-like cytotoxic function of bystander-activated CD8(+) T cells is associated with liver injury in acute hepatitis A. Immunity 48, 161-173.e165 https://doi.org/10.1016/j.immuni.2017.11.025
- Lee HG, Lee JU, Kim DH, Lim S, Kang I and Choi JM (2019) Pathogenic function of bystander-activated memory-like CD4(+) T cells in autoimmune encephalomyelitis. Nat Commun 10, 709 https://doi.org/10.1038/s41467-019-08482-w
- Simoni Y, Becht E, Fehlings M et al (2018) Bystander CD8(+) T cells are abundant and phenotypically distinct in human tumour infiltrates. Nature 557, 575-579 https://doi.org/10.1038/s41586-018-0130-2
- Tough DF, Borrow P and Sprent J (1996) Induction of bystander T cell proliferation by viruses and type I interferon in vivo. Science 272, 1947-1950 https://doi.org/10.1126/science.272.5270.1947
- Tough DF, Sun S and Sprent J (1997) T cell stimulation in vivo by lipopolysaccharide (LPS). J Exp Med 185, 2089-2094 https://doi.org/10.1084/jem.185.12.2089
- Gangappa S, Deshpande SP and Rouse BT (1999) Bystander activation of CD4(+) T cells can represent an exclusive means of immunopathology in a virus infection. Eur J Immunol 29, 3674-3682 https://doi.org/10.1002/(SICI)1521-4141(199911)29:11<3674::AID-IMMU3674>3.0.CO;2-7
- Yang HY, Dundon PL, Nahill SR and Welsh RM (1989) Virus-induced polyclonal cytotoxic T lymphocyte stimulation. J Immunol 142, 1710-1718
- Unutmaz D, Pileri P and Abrignani S (1994) Antigen-independent activation of naive and memory resting T cells by a cytokine combination. J Exp Med 180, 1159-1164 https://doi.org/10.1084/jem.180.3.1159
- Zarozinski CC and Welsh RM (1997) Minimal bystander activation of CD8 T cells during the virus-induced poly-clonal T cell response. J Exp Med 185, 1629-1639 https://doi.org/10.1084/jem.185.9.1629
- Murali-Krishna K, Altman JD, Suresh M et al (1998) Counting antigen-specific CD8 T cells: a reevaluation of bystander activation during viral infection. Immunity 8, 177-187 https://doi.org/10.1016/S1074-7613(00)80470-7
- Polley R, Zubairi S and Kaye PM (2005) The fate of heterologous CD4+ T cells during Leishmania donovani infection. Eur J Immunol 35, 498-504 https://doi.org/10.1002/eji.200425436
- Guo L, Wei G, Zhu J et al (2009) IL-1 family members and STAT activators induce cytokine production by Th2, Th17, and Th1 cells. Proc Natl Acad Sci U S A 106, 13463-13468 https://doi.org/10.1073/pnas.0906988106
- Guo L, Huang Y, Chen X, Hu-Li J, Urban JF Jr and Paul WE (2015) Innate immunological function of TH2 cells in vivo. Nat Immunol 16, 1051-1059 https://doi.org/10.1038/ni.3244
- Pellicci DG, Koay HF and Berzins SP (2020) Thymic development of unconventional T cells: how NKT cells, MAIT cells and γδ T cells emerge. Nat Rev Immunol 20, 756-770 https://doi.org/10.1038/s41577-020-0345-y
- Leite-De-Moraes MC, Hameg A, Arnould A et al (1999) A distinct IL-18-induced pathway to fully activate NK T lymphocytes independently from TCR engagement. J Immunol 163, 5871-5876
- Terashima A, Watarai H, Inoue S et al (2008) A novel subset of mouse NKT cells bearing the IL-17 receptor B responds to IL-25 and contributes to airway hyperreactivity. J Exp Med 205, 2727-2733 https://doi.org/10.1084/jem.20080698
- Doisne JM, Soulard V, Becourt C et al (2011) Cutting edge: crucial role of IL-1 and IL-23 in the innate IL-17 response of peripheral lymph node NK1.1- invariant NKT cells to bacteria. J Immunol 186, 662-666 https://doi.org/10.4049/jimmunol.1002725
- Ma R, Yuan D, Guo Y, Yan R and Li K (2020) Immune effects of γδ T cells in colorectal cancer: a review. Front Immunol 11, 1600 https://doi.org/10.3389/fimmu.2020.01600
- Haas JD, Gonzalez FH, Schmitz S et al (2009) CCR6 and NK1.1 distinguish between IL-17A and IFN-gamma-producing gammadelta effector T cells. Eur J Immunol 39, 3488-3497 https://doi.org/10.1002/eji.200939922
- Kjer-Nielsen L, Patel O, Corbett AJ et al (2012) MR1 presents microbial vitamin B metabolites to MAIT cells. Nature 491, 717-723 https://doi.org/10.1038/nature11605
- Ussher JE, Bilton M, Attwod E et al (2014) CD161++ CD8+ T cells, including the MAIT cell subset, are specifically activated by IL-12+IL-18 in a TCR-independent manner. Eur J Immunol 44, 195-203 https://doi.org/10.1002/eji.201343509
- van Wilgenburg B, Scherwitzl I, Hutchinson EC et al (2016) MAIT cells are activated during human viral infections. Nat Commun 7, 11653 https://doi.org/10.1038/ncomms11653
- Swain SL, Hu H and Huston G (1999) Class II-independent generation of CD4 memory T cells from effectors. Science 286, 1381-1383 https://doi.org/10.1126/science.286.5443.1381
- Eberl G, Brawand P and MacDonald HR (2000) Selective bystander proliferation of memory CD4+ and CD8+ T cells upon NK T or T cell activation. J Immunol 165, 4305-4311 https://doi.org/10.4049/jimmunol.165.8.4305
- Chakir H, Lam DK, Lemay AM and Webb JR (2003) "Bystander polarization" of CD4+ T cells: activation with high-dose IL-2 renders naive T cells responsive to IL-12 and/or IL-18 in the absence of TCR ligation. Eur J Immunol 33, 1788-1798 https://doi.org/10.1002/eji.200323398
- Chung Y, Chang SH, Martinez GJ et al (2009) Critical regulation of early Th17 cell differentiation by interleukin-1 signaling. Immunity 30, 576-587 https://doi.org/10.1016/j.immuni.2009.02.007
- Ben-Sasson SZ, Caucheteux S, Crank M, Hu-Li J and Paul WE (2011) IL-1 acts on T cells to enhance the magnitude of in vivo immune responses. Cytokine 56, 122-125 https://doi.org/10.1016/j.cyto.2011.07.006
- Lee YK, Landuyt AE, Lobionda S, Sittipo P, Zhao Q and Maynard CL (2017) TCR-independent functions of Th17 cells mediated by the synergistic actions of cytokines of the IL-12 and IL-1 families. PLoS One 12, e0186351 https://doi.org/10.1371/journal.pone.0186351
- Jiang W, Younes SA, Funderburg NT et al (2014) Cycling memory CD4+ T cells in HIV disease have a diverse T cell receptor repertoire and a phenotype consistent with bystander activation. J Virol 88, 5369-5380 https://doi.org/10.1128/JVI.00017-14
- van Aalst S, Ludwig IS, van der Zee R, van Eden W and Broere F (2017) Bystander activation of irrelevant CD4+ T cells following antigen-specific vaccination occurs in the presence and absence of adjuvant. PLoS One 12, e0177365 https://doi.org/10.1371/journal.pone.0177365
- Zhang X, Sun S, Hwang I, Tough DF and Sprent J (1998) Potent and selective stimulation of memory-phenotype CD8+ T cells in vivo by IL-15. Immunity 8, 591-599 https://doi.org/10.1016/S1074-7613(00)80564-6
- Lu J, Giuntoli RL 2nd, Omiya R, Kobayashi H, Kennedy R and Celis E (2002) Interleukin 15 promotes antigen-independent in vitro expansion and long-term survival of antitumor cytotoxic T lymphocytes. Clin Cancer Res 8, 3877-3884
- Tietze JK, Wilkins DE, Sckisel GD et al (2012) Delineation of antigen-specific and antigen-nonspecific CD8(+) memory T-cell responses after cytokine-based cancer immunotherapy. Blood 119, 3073-3083 https://doi.org/10.1182/blood-2011-07-369736
- Chu T, Tyznik AJ, Roepke S et al (2013) Bystander-activated memory CD8 T cells control early pathogen load in an innate-like, NKG2D-dependent manner. Cell Rep 3, 701-708 https://doi.org/10.1016/j.celrep.2013.02.020
- Crosby EJ, Goldschmidt MH, Wherry EJ and Scott P (2014) Engagement of NKG2D on bystander memory CD8 T cells promotes increased immunopathology following Leishmania major infection. PLoS Pathog 10, e1003970 https://doi.org/10.1371/journal.ppat.1003970
- Younes SA, Freeman ML, Mudd JC et al (2016) IL-15 promotes activation and expansion of CD8+ T cells in HIV-1 infection. J Clin Invest 126, 2745-2756 https://doi.org/10.1172/jci85996
- Seo IH, Eun HS, Kim JK et al (2021) IL-15 enhances CCR5-mediated migration of memory CD8(+) T cells by upregulating CCR5 expression in the absence of TCR stimulation. Cell Rep 36, 109438 https://doi.org/10.1016/j.celrep.2021.109438
- Lees JR, Sim J and Russell JH (2010) Encephalitogenic T-cells increase numbers of CNS T-cells regardless of antigen specificity by both increasing T-cell entry and preventing egress. J Neuroimmunol 220, 10-16 https://doi.org/10.1016/j.jneuroim.2009.11.017
- Walsh JT, Hendrix S, Boato F et al (2015) MHCII-independent CD4+ T cells protect injured CNS neurons via IL-4. J Clin Invest 125, 699-714 https://doi.org/10.1172/JCI76210
- Van Kaer L, Postoak JL, Wang C, Yang G and Wu L (2019) Innate, innate-like and adaptive lymphocytes in the pathogenesis of MS and EAE. Cell Mol Immunol 16, 531-539 https://doi.org/10.1038/s41423-019-0221-5
- Jones RE, Kay T, Keller T and Bourdette D (2003) Nonmyelinspecific T cells accelerate development of central nervous system APC and increase susceptibility to experimental autoimmune encephalomyelitis. J Immunol 170, 831-837 https://doi.org/10.4049/jimmunol.170.2.831
- Reynolds JM, Pappu BP, Peng J et al (2010) Toll-like receptor 2 signaling in CD4(+) T lymphocytes promotes T helper 17 responses and regulates the pathogenesis of autoimmune disease. Immunity 32, 692-702 https://doi.org/10.1016/j.immuni.2010.04.010
- Reynolds JM, Martinez GJ, Chung Y and Dong C (2012) Toll-like receptor 4 signaling in T cells promotes autoimmune inflammation. Proc Natl Acad Sci U S A 109, 13064-13069 https://doi.org/10.1073/pnas.1120585109
- Ferreira TB, Hygino J, Wing AC et al (2018) Different interleukin-17-secreting Toll-like receptor(+) T-cell subsets are associated with disease activity in multiple sclerosis. Immunology 154, 239-252 https://doi.org/10.1111/imm.12872
- Nogai A, Siffrin V, Bonhagen K et al (2005) Lipopolysaccharide injection induces relapses of experimental autoimmune encephalomyelitis in nontransgenic mice via bystander activation of autoreactive CD4+ cells. J Immunol 175, 959-966 https://doi.org/10.4049/jimmunol.175.2.959
- Tan LC, Mowat AG, Fazou C et al (2000) Specificity of T cells in synovial fluid: high frequencies of CD8(+) T cells that are specific for certain viral epitopes. Arthritis Res 2, 154-164 https://doi.org/10.1186/ar80
- Kobayashi M, Yasui N, Ishimaru N, Arakaki R and Hayashi Y (2004) Development of autoimmune arthritis with aging via bystander T cell activation in the mouse model of Sjogren's syndrome. Arthritis Rheum 50, 3974-3984 https://doi.org/10.1002/art.20679
- Sobek V, Birkner N, Falk I et al (2004) Direct Toll-like receptor 2 mediated co-stimulation of T cells in the mouse system as a basis for chronic inflammatory joint disease. Arthritis Res Ther 6, R433-446 https://doi.org/10.1186/ar1212
- Brennan FM, Smith NM, Owen S et al (2008) Resting CD4+ effector memory T cells are precursors of bystander-activated effectors: a surrogate model of rheumatoid arthritis synovial T-cell function. Arthritis Res Ther 10, R36 https://doi.org/10.1186/ar2390
- Horwitz MS, Bradley LM, Harbertson J, Krahl T, Lee J and Sarvetnick N (1998) Diabetes induced by Coxsackie virus: initiation by bystander damage and not molecular mimicry. Nat Med 4, 781-785 https://doi.org/10.1038/nm0798-781
- Pane JA and Coulson BS (2015) Lessons from the mouse: potential contribution of bystander lymphocyte activation by viruses to human type 1 diabetes. Diabetologia 58, 1149-1159 https://doi.org/10.1007/s00125-015-3562-3
- Simoni Y, Gautron AS, Beaudoin L et al (2011) NOD mice contain an elevated frequency of iNKT17 cells that exacerbate diabetes. Eur J Immunol 41, 3574-3585 https://doi.org/10.1002/eji.201141751
- Markle JG, Mortin-Toth S, Wong AS, Geng L, Hayday A and Danska JS (2013) γδ T cells are essential effectors of type 1 diabetes in the nonobese diabetic mouse model. J Immunol 190, 5392-5401 https://doi.org/10.4049/jimmunol.1203502
- Rouxel O, Da Silva J, Beaudoin L et al (2017) Cytotoxic and regulatory roles of mucosal-associated invariant T cells in type 1 diabetes. Nat Immunol 18, 1321-1331 https://doi.org/10.1038/ni.3854
- Lertmemongkolchai G, Cai G, Hunter CA and Bancroft GJ (2001) Bystander activation of CD8+ T cells contributes to the rapid production of IFN-gamma in response to bacterial pathogens. J Immunol 166, 1097-1105 https://doi.org/10.4049/jimmunol.166.2.1097
- Doisne JM, Urrutia A, Lacabaratz-Porret C et al (2004) CD8+ T cells specific for EBV, cytomegalovirus, and influenza virus are activated during primary HIV infection. J Immunol 173, 2410-2418 https://doi.org/10.4049/jimmunol.173.4.2410
- Bastidas S, Graw F, Smith MZ, Kuster H, Gunthard HF and Oxenius A (2014) CD8+ T cells are activated in an antigen-independent manner in HIV-infected individuals. J Immunol 192, 1732-1744 https://doi.org/10.4049/jimmunol.1302027
- Nakamura R, Maeda N, Shibata K, Yamada H, Kase T and Yoshikai Y (2010) Interleukin-15 is critical in the pathogenesis of influenza a virus-induced acute lung injury. J Virol 84, 5574-5582 https://doi.org/10.1128/JVI.02030-09
- Gregorova M, Morse D, Brignoli T et al (2020) Post-acute COVID-19 associated with evidence of bystander T-cell activation and a recurring antibiotic-resistant bacterial pneumonia. Elife 9, e63430 https://doi.org/10.7554/eLife.63430
- Joncker NT, Marloie MA, Chernysheva A et al (2006) Antigen-independent accumulation of activated effector/memory T lymphocytes into human and murine tumors. Int J Cancer 118, 1205-1214 https://doi.org/10.1002/ijc.21472
- Duhen T, Duhen R, Montler R et al (2018) Co-expression of CD39 and CD103 identifies tumor-reactive CD8 T cells in human solid tumors. Nat Commun 9, 2724 https://doi.org/10.1038/s41467-018-05072-0
- Scheper W, Kelderman S, Fanchi LF et al (2019) Low and variable tumor reactivity of the intratumoral TCR repertoire in human cancers. Nat Med 25, 89-94 https://doi.org/10.1038/s41591-018-0266-5
- Ponzetta A, Carriero R, Carnevale S et al (2019) Neutrophils driving unconventional T cells mediate resistance against murine sarcomas and selected human tumors. Cell 178, 346-360.e324 https://doi.org/10.1016/j.cell.2019.05.047
- Rosato PC, Wijeyesinghe S, Stolley JM et al (2019) Virusspecific memory T cells populate tumors and can be repurposed for tumor immunotherapy. Nat Commun 10, 567 https://doi.org/10.1038/s41467-019-08534-1
- Danahy DB, Berton RR and Badovinac VP (2020) Cutting edge: antitumor immunity by pathogen-specific CD8 T cells in the absence of cognate antigen recognition. J Immunol 204, 1431-1435 https://doi.org/10.4049/jimmunol.1901172
- Newman JH, Chesson CB, Herzog NL et al (2020) Intratumoral injection of the seasonal flu shot converts immunologically cold tumors to hot and serves as an immunotherapy for cancer. Proc Natl Acad Sci U S A 117, 1119-1128 https://doi.org/10.1073/pnas.1904022116